SEC Form 4 · accession 0001354488-16-008520
CorMedix Inc. · CRMD
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Michael W George
Director
Period of report
Nov 14, 2016
Accepted (ET)
Nov 16, 2016 · 4:07 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001410098
Table I — non-derivative securities
No Table I lines on this filing.
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Phantom StockF1,F2 | $0.00 | Nov 14, 2016 | P | 4,143 | A | — | — | Common Stock | 4,143 | 4,143 | D |
| Stock Option (Right to buy Common Stock)F3 | $2.11 | holding | — | — | — | — | Apr 5, 2024 | Common Stock | 15,000 | 15,000 | D |
| Stock Option (Right to buy Common Stock)F4 | $2.79 | holding | — | — | — | — | Feb 27, 2024 | Common Stock | 30,000 | 30,000 | D |
| Stock Option (Right to buy Common Stock)F4 | $5.62 | holding | — | — | — | — | Mar 1, 2025 | Common Stock | 50,000 | 50,000 | D |
| Phantom StockF1 | $0.00 | holding | — | — | — | — | — | Common Stock | 1,847 | 1,847 | D |
| Phantom StockF1 | $0.00 | holding | — | — | — | — | — | Common Stock | 1,176 | 1,176 | D |
| Phantom StockF1 | $0.00 | holding | — | — | — | — | — | Common Stock | 2,459 | 2,459 | D |
| Phantom StockF1 | $0.00 | holding | — | — | — | — | — | Common Stock | 3,125 | 3,125 | D |
| Stock Option (Right to buy Common Stock)F4 | $1.91 | holding | — | — | — | — | Feb 21, 2026 | Common Stock | 90,000 | 90,000 | D |
| Phantom StockF1 | $0.00 | holding | — | — | — | — | — | Common Stock | 3,968 | 3,968 | D |
| Phantom StockF1 | $0.00 | holding | — | — | — | — | — | Common Stock | 2,767 | 2,767 | D |
| Phantom StockF1 | $0.00 | holding | — | — | — | — | — | Common Stock | 4,335 | 4,335 | D |
Explanation of responses
- F1Each share of phantom stock is the economic equivalent of one share of common stock. The shares of phantom stock become payable in common stock on the tenth business day of January of the year following the reporting person's termination of service as a director.
- F2These shares were credited automatically to the reporting person's account pursuant to the reporting person's election to defer the receipt of cash compensation of directors' fees.
- F35,000 shares vest upon completion of the April 2014 milestone, 10,000 shares vest upon completion of another milestone by the third quarter of 2014.
- F4These options vest in full on the first anniversary of the date of grant.